Net shares · 90d
-220.4K
0 buy · 220.4K sell
Net value · 90d
-$879.5K
$0 in · $879.5K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
1
0 buy · 220.4K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 90d
-
CLOV Sell·S
CEO, Counterpart Health · 10b5-1
$879.5K
220.4K sh · $3.99
Own -14%
-
CLOV Other·F
CEO, Counterpart Health
$47.9K
23.5K sh · $2.04
Own -2%
-
CLOV Grant·A
CEO, Counterpart Health
$0
267.8K sh
Own +29%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| May 28, 2026 | CLOV | Sell S | 220.4K | $879.5K |
| Apr 15, 2026 | CLOV | Other F | 23.5K | $47.9K |
| Apr 1, 2026 | CLOV | Grant A | 267.8K | $0 |
Buy Sell Non-market (grant · exercise · gift)
About Wai Conrad
This profile aggregates every SEC Form 4 insider transaction reported by Wai Conrad across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.